• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量口服米诺地尔对血压无显著影响:一项系统评价与荟萃分析。

Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis.

作者信息

Chen Matthew, Weichert Maggie, Guo William, Ruzic Robert, Briley James

机构信息

Department of Dermatology, Stony Brook Dermatology, Stony Brook, New York.

Department of Dermatology, Stony Brook Dermatology, Stony Brook, New York.

出版信息

J Am Acad Dermatol. 2025 Mar;92(3):554-555. doi: 10.1016/j.jaad.2024.10.057. Epub 2024 Nov 7.

DOI:10.1016/j.jaad.2024.10.057
PMID:39521141
Abstract

INTRODUCTION

Minoxidil, traditionally used as an antihypertensive, is now widely used for treating various forms of alopecia due to its vasodilatory effects. While topical minoxidil has been the standard treatment, low-dose oral minoxidil (LDOM) is emerging as an effective alternative. This study investigates LDOM's potential hypotensive effects.

METHODS

Studies were selected based on criteria such as the use of LDOM (≤5 mg/day) and reporting on blood pressure changes. Mean differences (MDs) were calculated for mean arterial pressure (MAP), systolic blood pressure, diastolic blood pressure, and heart rate.

RESULTS

LDOM did not significantly alter systolic blood pressure (MD: -0.13, 95% CI: -2.67-2.41) or diastolic blood pressure (MD: -1.25, 95% CI: -3.21-0.71). Though MAP was not significantly altered, there was a strong tendency toward decreased MAP (MD: -1.92, 95% CI: -4.00-0.17). There was a significant increase in heart rate (MD: 2.67, 95% CI: 0.34-5.01). Hypotensive symptoms were reported in 119 patients (5.0%), but no hypotensive episodes were observed. Hypertrichosis was the most frequent side effect, leading to 34.6% of discontinuations.

LIMITATIONS

Studies lacked control groups and showed variability in dosing regimens and blood pressure monitoring.

CONCLUSION

LDOM appears to be a safe treatment for alopecia with no significant impact on blood pressure.

摘要

引言

米诺地尔传统上用作抗高血压药物,由于其血管舒张作用,现在广泛用于治疗各种形式的脱发。虽然局部用米诺地尔一直是标准治疗方法,但低剂量口服米诺地尔(LDOM)正成为一种有效的替代方法。本研究调查了LDOM的潜在降压作用。

方法

根据使用LDOM(≤5毫克/天)和报告血压变化等标准选择研究。计算平均动脉压(MAP)、收缩压、舒张压和心率的平均差异(MDs)。

结果

LDOM未显著改变收缩压(MD:-0.13,95%CI:-2.67-2.41)或舒张压(MD:-1.25,95%CI:-3.21-0.71)。虽然MAP没有显著改变,但有强烈的MAP下降趋势(MD:-1.92,95%CI:-4.00-0.17)。心率显著增加(MD:2.67,95%CI:0.34-5.01)。119名患者(5.0%)报告有低血压症状,但未观察到低血压发作。多毛症是最常见的副作用,导致34.6%的患者停药。

局限性

研究缺乏对照组,给药方案和血压监测存在差异。

结论

LDOM似乎是一种安全的脱发治疗方法,对血压无显著影响。

相似文献

1
Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis.低剂量口服米诺地尔对血压无显著影响:一项系统评价与荟萃分析。
J Am Acad Dermatol. 2025 Mar;92(3):554-555. doi: 10.1016/j.jaad.2024.10.057. Epub 2024 Nov 7.
2
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.低剂量口服米诺地尔用于脱发患者:一项国际改良德尔菲共识声明。
JAMA Dermatol. 2025 Jan 1;161(1):87-95. doi: 10.1001/jamadermatol.2024.4593.
3
Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review.低剂量口服米诺地尔治疗脱发:综述
Skin Appendage Disord. 2023 Dec;9(6):423-437. doi: 10.1159/000531890. Epub 2023 Sep 27.
4
To evaluate hypertrichosis with low dose oral minoxidil and spironolactone combination therapy for alopecia.评估小剂量口服米诺地尔和螺内酯联合治疗脱发引起的多毛症。
Arch Dermatol Res. 2024 Aug 12;316(8):510. doi: 10.1007/s00403-024-03261-0.
5
Evaluation of Pericardial Effusions in Alopecia Patients on Low-Dose Oral Minoxidil Therapy.评估低剂量口服米诺地尔治疗脱发患者的心包积液。
J Drugs Dermatol. 2024 Sep 1;23(9):725-728. doi: 10.36849/JDD.8029.
6
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.低剂量口服米诺地尔治疗脱发的安全性:一项对 1404 例患者的多中心研究。
J Am Acad Dermatol. 2021 Jun;84(6):1644-1651. doi: 10.1016/j.jaad.2021.02.054. Epub 2021 Feb 24.
7
Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials.口服米诺地尔与外用溶液治疗雄激素性脱发的疗效和安全性:一项随机临床试验的荟萃分析
Int J Dermatol. 2025 Mar;64(3):479-484. doi: 10.1111/ijd.17524. Epub 2024 Oct 19.
8
Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring.口服7.5毫克米诺地尔治疗脱发,在24小时动态心电图监测和24小时动态血压监测中会增加心率,血压无变化。
An Bras Dermatol. 2024 Sep-Oct;99(5):734-736. doi: 10.1016/j.abd.2023.08.016. Epub 2024 May 20.
9
Low-Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions.低剂量口服米诺地尔及其相关不良事件:对美国食品药品监督管理局不良事件报告系统(FAERS)的分析,重点关注心包积液。
J Cosmet Dermatol. 2025 Jan;24(1):e16574. doi: 10.1111/jocd.16574. Epub 2024 Sep 26.
10
Response to "Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study".对“低剂量口服米诺地尔治疗雄激素性脱发与临床上显著的血压变化无关:一项回顾性研究”的回应
J Am Acad Dermatol. 2024 Jul;91(1):e11-e12. doi: 10.1016/j.jaad.2024.01.089. Epub 2024 Mar 16.

引用本文的文献

1
Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review.低剂量口服米诺地尔治疗脱发的不良事件的特征与管理:一项叙述性综述
J Clin Med. 2025 Mar 7;14(6):1805. doi: 10.3390/jcm14061805.